BPC-157 BPC-157 is a synthetic peptide demonstrated to accelerate tissue repair and reduce inflammation in animal models
The ability of a phagocyte to perform multiple rounds of phagocytosis of ACs in a relatively short timecalled continuous efferocytosisis essential in scenarios where the ACs:phagocytes ratio is high, such as after an acute inflammatory process or tissue injury
Patients with: Personal or family history of Medullary thyroid cancer MEN2 syndrome Severe gastroparesis Pregnancy/ breastfeeding Pancreatitis or breastfeeding Severe depression Eating disorders Liver or kidney disease (caution advised) Why GLP-1 and Inflammation and Arthritis Matter We now understand that GLP-1 medications are not just weight loss drugs. They are anti-inflammatory, immune-modulating, metabolic medications that can dramatically shift health outcomes for patients with arthritis and autoimmune diseases
After reviewing new molecules for the ADA 2025 conference, Id be remiss to not review the new data and molecules of interest for Obesity Week 2025, especially since I actually went to the conference
Andrew: They take your blood, they spin it down, they take the platelets [crosstalk] Craig: Right
Kong N, Tao W, Ling X, Wang J, Xiao Y, Shi S, et al